Equillium (EQ) Other Non Operating Income (2019 - 2026)
Equillium (EQ) reported Other Non Operating Income of $299000.0 for Q1 2026, up 38.43% year-over-year from $216000.0 in Q1 2025, and up 59.89% quarter-over-quarter from $187000.0 in Q4 2025.
Equillium (EQ) Other Non Operating Income (2019 - 2026) Analysis & Trends
Equillium (EQ) has 8 years of Other Non Operating Income data on file, last reported at $299000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $299000.0, up 38.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 83.08% YoY), and the FY2025 annual result was $1.2 million, up 119.54% from the prior year.
- Other Non Operating Income improved to $299000.0 in Q1 2026 per EQ's latest filing, from $187000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $874000.0 in Q4 2023 and troughed at -$735000.0 in Q4 2024.
- A 5-year average of $208411.8 and a median of $256000.0 in 2023 frame the typical range for Other Non Operating Income.
- On a YoY basis, Other Non Operating Income climbed as much as 3540.91% in 2022 and fell as far as 894.83% in 2022.
- A 5-year view of Other Non Operating Income shows it stood at $801000.0 in 2022, then increased by 9.11% to $874000.0 in 2023, then slumped by 184.1% to -$735000.0 in 2024, then surged by 125.44% to $187000.0 in 2025, then soared by 59.89% to $299000.0 in 2026.
- Business Quant data shows EQ's Other Non Operating Income at $299000.0 in Q1 2026, $187000.0 in Q4 2025, and $345000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 299,000.00 |
| Dec 31, 2025 | 187,000.00 |
| Sep 30, 2025 | 345,000.00 |
| Jun 30, 2025 | 489,000.00 |
| Mar 31, 2025 | 216,000.00 |
| Dec 31, 2024 | -735,000.00 |
| Sep 30, 2024 | 672,000.00 |
| Jun 30, 2024 | 568,000.00 |
| Mar 31, 2024 | 57,000.00 |
| Dec 31, 2023 | 874,000.00 |
| Sep 30, 2023 | 409,000.00 |
| Jun 30, 2023 | 256,000.00 |
| Mar 31, 2023 | -179,000.00 |
| Dec 31, 2022 | 801,000.00 |
| Sep 30, 2022 | -281,000.00 |
| Jun 30, 2022 | -577,000.00 |
| Mar 31, 2022 | 142,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | -163,000.00 |
| Jun 30, 2021 | -58,000.00 |